Point mutations of the mTOR-RHEB pathway in renal cell carcinoma-Reference-Cited by-同舟云学术

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma

Published:2015-07-20 Issue:20 Volume:6 Page:17895-17910
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ghosh Arindam P.¹,Marshall Christopher B.²,Coric Tatjana³,Shim Eun-hee¹,Kirkman Richard¹,Ballestas Mary E.⁴,Ikura Mitsuhiko²,Bjornsti Mary-Ann³,Sudarshan Sunil¹

Affiliation:

1. Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA

2. Department of Medical Biophysics, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada

3. Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama, USA

4. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis;Oncogene;2024-09-13

2. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

3. The Patent Landscape of mTOR and PTEN Targets;Recent Advances in Anti-Infective Drug Discovery;2024-08

4. Synthesis, spectroscopic characterization, crystal structure, DFT calculations, Hirshfeld surface analysis and anti-cancer activities of (4-amino-6-(dimethylamino)-1,3,5-triazin-2-yl)methyl 2-acetoxybenzoate compound;Journal of Molecular Structure;2024-07

5. The emerging genetic landscape of renal cell carcinoma;Diagnostic Molecular Pathology;2024